PDS Biotechnology Cash from Financing (TTM) Insights

PDS Biotechnology Corp (PDSB)

3.35 -0.04 (-1.18%) USD | NASDAQ | Apr 30, 16:00

3.40 +0.05 (+1.49%) Pre-Market: 08:40

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	16.38M
September 30, 2023	15.32M
June 30, 2023	39.07M
March 31, 2023	38.85M
December 31, 2022	34.29M
September 30, 2022	24.58M
June 30, 2022	0.1534M
March 31, 2022	48.90M
December 31, 2021	48.89M
September 30, 2021	48.89M
June 30, 2021	66.55M
March 31, 2021	17.79M
December 31, 2020	29.83M
September 30, 2020	29.83M
June 30, 2020	12.04M
March 31, 2020	12.04M
December 31, 2019	0.75M

Date	Value
September 30, 2019	-20.74M
June 30, 2019	-20.57M
March 31, 2019	-20.57M
December 31, 2018	-20.27M
September 30, 2018	1.247M
June 30, 2018	1.125M
March 31, 2018	23.55M
December 31, 2017	22.55M
September 30, 2017	22.53M
June 30, 2017	33.19M
March 31, 2017	10.24M
December 31, 2016	9.085M
September 30, 2016	93.68M
June 30, 2016	82.74M
March 31, 2016	135.50M
December 31, 2015	139.52M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-20.74M

Minimum

Sep 2019

66.55M

Maximum

Jun 2021

23.31M

Average

24.58M

Median

Sep 2022

Cash from Financing (TTM) Benchmarks